文献速递新发突发、热带与寄生虫病

妊娠期疟疾间歇性预防治疗对婴儿结局的影响:随机对照试验

Impact of Intermittent Preventive Treatment for Malaria in Pregnancy With Sulfadoxine-Pyrimethamine, Dihydroartemisinin-Piperaquine, and Their Combination on Infant Outcomes: A Randomized Controlled Trial.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该双盲随机对照试验比较妊娠期间歇性预防治疗(IPTp)方案SP、DP及DP+SP对婴儿至12月龄的疟疾负担与生长影响。纳入871名婴儿,临床疟疾发病率在三组间相似,但含DP方案组婴儿出生时消瘦患病率短暂升高,3-6月龄时差异消失。

要点

  • IPTp-DP与IPTp-SP对婴儿临床疟疾发病率无显著差异。
  • 含DP方案组婴儿出生时消瘦风险短暂增加,3-6月龄缓解。
  • 婴儿总体寄生虫携带率21.8%,组间无差异。

核心结论

  • 三种IPTp方案对婴儿结局无显著差异,仅含DP方案组出生时消瘦风险短暂增加。

研究设计与样本

  • 双盲随机对照试验,纳入871名婴儿,随访至12月龄。

主要发现

  • 每月访视总体寄生虫携带率为21.8%,组间相似。
  • 出生时消瘦患病率:IPTp-DP+SP vs SP的PR为2.30(95%CI 1.07-4.97),IPTp-DP vs SP的PR为2.25(95%CI 1.03-4.94),3-6月龄时差异消失。

临床怎么用

  • 含DP的IPTp方案对婴儿疟疾负担无显著影响,但需关注出生时消瘦风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin-piperaquine (IPTp-DP) is more effective than sulfadoxine-pyrimethamine (IPTp-SP) at reducing the burden of malaria in pregnancy. Paradoxically, IPTp-DP has been associated with lower birth weights compared with IPTp-SP. Whether the impacts of IPTp-DP extend after birth is unknown. METHODS: We conducted a double-blind randomized controlled trial to compare malaria burden and growth among infants born to mothers who were randomized to monthly IPTp-SP, IPTp-DP, or IPTp-DP + SP. Infants were followed to 12 months of age by passive and active surveillance. The primary outcome was clinical malaria incidence; secondary outcomes included parasite prevalence and infant growth outcomes. RESULTS: Among 871 infants enrolled, there were 667 episodes of clinical malaria. Compared to infants whose mothers received IPTp-SP, malaria incidence was similar in infants whose mothers received IPTp-DP (incidence rate ratio [IRR] 1.04, 95% CI .78-1.38) or IPTp-DP + SP (IRR = 0.93, 95% CI .68-1.26). Overall parasite prevalence at monthly visits was 21.8%. Parasite prevalence was also similar between groups. The prevalence of wasting at birth was higher in infants whose mothers received IPTp-DP + SP (prevalence ratio [PR] = 2.30, 95% CI 1.07-4.97) or IPTp-DP (PR = 2.25, 95% CI 1.03-4.94) than those that received IPTp-SP, but differences between groups resolved by 3-6 months of age. CONCLUSIONS: There were no significant differences in infant outcomes between the 3 IPTp arms apart from a transiently increased risk of wasting among infants born to mothers who received DP-containing IPTp regimens.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Nankabirwa JI, Kakuru A, Nguyen AT, et al. Impact of Intermittent Preventive Treatment for Malaria in Pregnancy With Sulfadoxine-Pyrimethamine, Dihydroartemisinin-Piperaquine, and Their Combination on Infant Outcomes: A Randomized Controlled Trial. Clin Infect Dis. 2026. PMID: 42007686. doi:10.1093/cid/ciag253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。